Recent advances in Toll-like receptors and anterior uveitis

Clinical and Experimental Ophthalmology

Volumn 40, Issue 8, 2012, Pages 821-828

  Chang, John H ^a,c   Mccluskey, Peter J ^a,b   Wakefield, Denis ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Anterior uveitis; Immunology; Inflammation; Uveitis

Indexed keywords

CD14 ANTIGEN; CYTOKINE; ENDOTOXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA B27 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PATTERN RECOGNITION RECEPTOR; RANTES; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; BEHCET DISEASE; CYTOKINE RELEASE; DENDRITIC CELL; ENVIRONMENTAL FACTOR; EXPERIMENTAL MODEL; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAM NEGATIVE BACTERIUM; HEREDITY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; IRIDOCYCLITIS; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; UVEITIS;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; TOLL-LIKE RECEPTORS; UVEITIS, ANTERIOR;

EID: 84869081625     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2012.02797.x     Document Type: Review

References (52)

1. Chang JH, Wakefield D. Uveitis: a global perspective. Ocul Immunol Inflamm 2002; 10: 263-79.
2. Chang JH, McCluskey P, Wakefield D. Expression of toll-like receptor 4 and its associated lipopolysaccharide receptor complex by resident antigen-presenting cells in the human uvea. Invest Ophthalmol Vis Sci 2004; 45: 1871-8.
3. Chang JH, McCluskey PJ, Wakefield D. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br J Ophthalmol 2006; 90: 103-8.
4. Wakefield D, Gray P, Chang J, Di Girolamo N, McCluskey P. The role of PAMPs and DAMPs in the pathogenesis of acute and recurrent anterior uveitis. Br J Ophthalmol 2010; 94: 271-4.
5. Nobelprize.org - The Official Website of The Nobel Prize, Ljunggren H, Scheynius A, Klareskog L. Scientific background: activation of the immune system 2011. Accessed February 2012. Available from: http://www.nobelprize.org/nobel_prizes/medicine/laureates/2011/advanced.html
6. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11: 373-84.
7. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34: 637-50.
8. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011; 30: 16-34.
9. Yu L, Wang L, Chen S. Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med 2010; 14: 2592-603.
10. Matzinger P. The danger model: a renewed sense of self. Science 2002; 296: 301-5.
11. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454: 428-35.
12. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
13. Chui JJ, Li MW, Di Girolamo N, Chang JH, McCluskey PJ, Wakefield D. Iris pigment epithelial cells express a functional lipopolysaccharide receptor complex. Invest Ophthalmol Vis Sci 2010; 51: 2558-67.
14. Brito BE, Zamora DO, Bonnah RA, Pan Y, Planck SR, Rosenbaum JT. Toll-like receptor 4 and CD14 expression in human ciliary body and TLR-4 in human iris endothelial cells. Exp Eye Res 2004; 79: 203-8.
15. Suhler EB, Smith JR, Giles TR etal. Infliximab therapy for refractory uveitis: 2-year results of a prospective trial. Arch Ophthalmol 2009; 127: 819-22.
16. Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR. Endotoxin-induced uveitis in rats as a model for human disease. Nature 1980; 286: 611-13.
17. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol 2005; 50: 364-88.
18. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005; 140: 509-16.
19. Dougados M, Baeten D. Spondyloarthritis. Lancet 2011; 377: 2127-37.
20. Wakefield D, Chang JH, Amjadi S, Maconochie Z, Abu El-Asrar A, McCluskey P. What is new HLA-B27 acute anterior uveitis? Ocul Immunol Inflamm 2011; 19: 139-44.
21. Verma MJ, Lloyd A, Rager H etal. Chemokines in acute anterior uveitis. Curr Eye Res 1997; 16: 1202-8.
22. Frey EA, Miller DS, Jahr TG etal. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992; 176: 1665-71.
23. Kitchens RL, Thompson PA. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 2005; 11: 225-9.
24. Haziot A, Rong GW, Bazil V, Silver J, Goyert SM. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood. J Immunol 1994; 152: 5868-76.
25. Streilein JW, Stein-Streilein J. Does innate immune privilege exist? J Leukoc Biol 2000; 67: 479-87.
26. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 2003; 3: 879-89.
27. Chang JH, Hampartzoumian T, Everett B, Lloyd A, McCluskey PJ, Wakefield D. Changes in Toll-like receptor (TLR)-2 and TLR4 expression and function but not polymorphisms are associated with acute anterior uveitis. Invest Ophthalmol Vis Sci 2007; 48: 1711-17.
28. Triantafilou M, Manukyan M, Mackie A etal. Lipoteichoic acid and toll-like receptor 2 internalization and targeting to the Golgi are lipid raft-dependent. J Biol Chem 2004; 279: 40882-9.
29. Nomura F, Akashi S, Sakao Y etal. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 2000; 164: 3476-9.
30. Lehner MD, Morath S, Michelsen KS, Schumann RR, Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J Immunol 2001; 166: 5161-7.
31. Marsik C, Mayr F, Cardona F, Derhaschnig U, Wagner OF, Jilma B. Endotoxaemia modulates Toll-like receptors on leucocytes in humans. Br J Haematol 2003; 121: 653-6.
32. Ziegler-Heitbrock HW. Molecular mechanism in tolerance to lipopolysaccharide. J Inflamm 1995; 45: 13-26.
33. Huhtinen M, Repo H, Laasila K etal. Systemic inflammation and innate immune response in patients with previous anterior uveitis. Br J Ophthalmol 2002; 86: 412-17.
34. Fox A, Hammer ME, Lill P, Burch TG, Burrish G. Experimental uveitis. Elicited by peptidoglycan-polysaccharide complexes, lipopolysaccharide, and muramyl dipeptide. Arch Ophthalmol 1984; 102: 1063-7.
35. Wells A, Pararajasegaram G, Baldwin M, Yang CH, Hammer M, Fox A. Uveitis and arthritis induced by systemic injection of streptococcal cell walls. Invest Ophthalmol Vis Sci 1986; 27: 921-5.
36. Merino G, Fujino Y, Hanashiro RK. Lipoteichoic acid as an inducer of acute uveitis in the rat. Invest Ophthalmol Vis Sci 1998; 39: 1251-6.
37. Chen J, Fujino Y, Takahashi T. Experimental uveitis induced by intravitreal or intravenous lipoteichoic acid in rabbits. Jpn J Ophthalmol 1999; 43: 368-74.
38. Li Q, Peng B, Whitcup SM, Jang SU, Chan CC. Endotoxin induced uveitis in the mouse: susceptibility and genetic control. Exp Eye Res 1995; 61: 629-32.
39. Poltorak A, He X, Smirnova I etal. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-8.
40. McMenamin PG, Crewe J, Morrison S, Holt PG. Immunomorphologic studies of macrophages and MHC class II-positive dendritic cells in the iris and ciliary body of the rat, mouse, and human eye. Invest Ophthalmol Vis Sci 1994; 35: 3234-50.
41. McMenamin PG. The distribution of immune cells in the uveal tract of the normal eye. Eye 1997; 11 (Pt 2): 183-93.
42. Chen W, Hu X, Zhao L, Li S, Lu H. Expression of toll-like receptor 4 in uvea-resident tissue macrophages during endotoxin-induced uveitis. Mol Vis 2009; 15: 619-28.
43. Wang J, Lu H, Hu X etal. Nuclear factor translocation and acute anterior uveitis. Mol Vis 2011; 17: 170-6.
44. Kezic J, Taylor S, Gupta S, Planck SR, Rosenzweig HL, Rosenbaum JT. Endotoxin-induced uveitis is primarily dependent on radiation-resistant cells and on MyD88 but not TRIF. J Leukoc Biol 2011; 90: 305-11.
45. Rosenbaum JT, Woods A, Kezic J, Planck SR, Rosenzweig HL. Contrasting ocular effects of local versus systemic endotoxin. Invest Ophthalmol Vis Sci 2011; 52: 6472-7.
46. Allensworth JJ, Planck SR, Rosenbaum JT, Rosenzweig HL. Investigation of the differential potentials of TLR agonists to elicit uveitis in mice. J Leukoc Biol 2011; 90(6):1159-66. Epub 2011 Sep 20.
47. Pratap DS, Lim LL, Wang JJ etal. The role of toll-like receptor variants in acute anterior uveitis. Mol Vis 2011; 17: 2970-7.
48. Ito R, Ota M, Meguro A etal. Investigation of association between TLR9 gene polymorphisms and VKH in Japanese patients. Ocul Immunol Inflamm 2011; 19: 202-5.
49. Asukata Y, Ota M, Meguro A etal. Lack of association between toll-like receptor 4 gene polymorphisms and sarcoidosis-related uveitis in Japan. Mol Vis 2009; 15: 2673-82.
50. Sada T, Ota M, Katsuyama Y etal. Association analysis of Toll-like receptor 7 gene polymorphisms and Behcet's disease in Japanese patients. Hum Immunol 2011; 72: 269-72.
51. Ben Dhifallah I, Lachheb J, Houman H, Hamzaoui K. Toll-like-receptor gene polymorphisms in a Tunisian population with Behcet's disease. Clin Exp Rheumatol 2009; 27: S58-62.
52. Clanchy FI, Sacre SM. Modulation of toll-like receptor function has therapeutic potential in autoimmune disease. Expert Opin Biol Ther 2010; 10: 1703-16.